Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Novo Threatens Hims & Hers With Suit Over GLP-1 'Knockoff' No Photo Available

Mark Payne

Novo Nordisk said in a Thursday announcement it plans to take legal action against Hims & Hers Health Inc. after the telehealth compan... (more story)

This Week's Healthcare Earnings: Novo, Elevance And More No Photo Available

Yeji Jesse Lee

More than half a dozen healthcare companies posted earnings this week, including big names like Pfizer, Elevance and Roche. Here's wha... (more story)

4 Things To Know As DOL Pitches Transparency For PBMs No Photo Available

Kellie Mejdrich

The U.S. Department of Labor's proposal to require pharmacy benefit managers to give employer-provided health plans detailed informati... (more story)